Close

Celgene (CELG) PT Lowered to $96 at RBC Capital Jul 30, 2019 03:57PM
Pre-Open Stock Movers 03/29: (BOXL) (PRGS) (CELG) Higher; (SGH) (RH) (CHMA) Lower (more...) Mar 29, 2019 09:27AM
Celgene (CELG) IP Risk to Ozanimod Overblown - RBC Mar 13, 2019 01:43PM
Celgene (CELG) Gets Another Legal Win, RBC Notes; Sees Risk as Lower Than Implied in Valuation Feb 11, 2019 01:32PM
Celgene (CELG) PT Raised to $98 at RBC Capital Feb 1, 2019 06:40AM
View Older Stories

Jan 3, 2019 03:59PM Bristol-Myers/Celgene Deal Likely Kicks Off 'Big Year' In Biopharma M&A - RBC
Jan 3, 2019 11:46AM RBC Capital Downgrades Celgene (CELG) to Sector Perform Following Acquisition
Dec 3, 2018 09:25AM Pre-Open Movers 12/03: (TSRO) (GBT) (NBEV) Higher; (OCUL) (BLUE) (GSK) Lower (more...)
Oct 9, 2018 01:40PM Celgene (CELG) Anti-CD47 Study Termination Seen Specific to AML/MDS - RBC
Aug 8, 2018 11:13AM RBC Discusses Celgene (CELG) Going Private at $120/Share Post-Elon
May 31, 2018 08:53AM Data Shows Funds Bailed On Celgene (CELG), Which Could Suggest a Rebound - RBC
May 21, 2018 12:56PM Celgene (CELG) Weakness on Golumbeski Exit 'Unfounded' - RBC
May 17, 2018 11:56AM FDA names drugmakers potentially acting to delay cheap generics
May 15, 2018 07:56AM Vertex Pharma (VRTX), Alexion Pharma (ALXN) Least Impacted from Trump Drug Policies - RBC
May 7, 2018 06:19AM RBC Capital Downgrades Celgene (CELG) to Outperform
Mar 26, 2018 07:45AM Celgene (CELG) Revlimid Settlement Likely - RBC
Mar 14, 2018 06:45AM RBC Explores a Possible LBO of Celgene (CELG)
Feb 28, 2018 07:55AM Celgene (CELG) PT Lowered to $131 at RBC Capital; Sees Modest Ozan Delay
Feb 1, 2018 07:30AM Celgene Corporation to Webcast at Upcoming Investor Conferences
Jan 22, 2018 09:29AM Pre-Open Movers 01/22: (BIVV) (JUNO) (ARRY) Higher; (SANM) (TEVA) (TWTR) Lower (more...)
Sep 15, 2017 02:22AM RBC Capital Starts Celgene (CELG) at Top Pick
Jul 6, 2017 09:30AM Pre-Open Movers 07/06: (HSNI) (BGNE) (CYTX) Higher; (EGLT) (TAHO) (AZZ) Lower (more...)
Feb 6, 2017 05:47PM Teva CEO exits in ongoing crisis of confidence at drugmaker
Aug 21, 2016 06:12PM Pfizer boosts cancer drug roster with $14 billion Medivation deal
Aug 2, 2016 03:41PM Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee
Jul 6, 2016 07:56AM 3 Key Takeaways as Medivation (MDVN) Enters Next Phase of Takeover Talks
Apr 4, 2016 01:52PM Biotech Seen Grinding Higher, Says RBC Capital (IBB)
Feb 1, 2016 07:30AM Celgene Corporation to Webcast at Upcoming Investor Conferences
Nov 16, 2015 02:24PM Celgene's (CELG) Victory vs Hayman Group Removes Overhang, Says RBC
Oct 27, 2015 02:46PM Celgene's (CELG) First IPR Not Relevant, Says RBC
Sep 29, 2015 11:00AM Buyers Seem Like Deer-in-Headlights: RBC Capital; Analyst Comments on Biotech Rout
Aug 25, 2015 10:49AM Analyst Touches on Read Through from Dismissal of Acorda (ACOR) IPR (BIIB) (CELG)
Jul 15, 2015 08:58AM UPDATE: Celgene (NASDAQ: CELG) Price Target Raised to $150 at RBC; Analyst Discusses Bull/Bear Case (RCPT)
Jun 30, 2015 09:26AM Pre-Open Stock Movers 06/30: (JUNO) (WSH) (PNR) Higher; (ETRM) (APOL) (SNE) Lower (more...)
Jun 30, 2015 07:09AM RBC Capital Views Celgene (CELG), Juno (JUNO) Deal as Incremental Positve
Feb 11, 2015 07:57AM Acorda (ACOR) IPR Patent Challenge Seen as Near-Term Overhang; RBC Maintains Outperform Rating
Oct 21, 2014 02:29PM Celgene's (CELG) GED-0301 Receives Positive Feedback from Docs - RBC
Oct 13, 2014 03:45PM RBC Capital Comments on Biotechs' Irish Tax Strategies; Gilead May See Modest EPS Impact (GILD) (AMGN)
Sep 12, 2014 08:54AM Celgene (CELG): Buy Yesterday's Weakness, say RBC
May 29, 2014 10:26AM Notable Analyst Rating Changes 05/29: (TWTR) (PANW) (DHI) Upgraded; (CELG) (DG) (PAGP) Downgraded
Apr 25, 2014 10:50AM Notable Analyst Rating Changes 04/25: (CELG) (SYNA) (WFC) Upgraded; (KLAC) (LLTC) (CYTK) Downgraded
Apr 2, 2014 09:33AM Pre-Open Stock Movers 4/2: (MNKD) (ENVI) (XLRN) Higher; (AGEN) (LQDT) (AGU) Lower (more...)
Dec 10, 2013 10:42AM Notable Analyst Rating Changes 12/10: (CELG) (GERN) (ARIA) Upgraded; (DGX) (HME) (CHL) Downgraded
Jan 8, 2013 02:33PM Notable 52-Week Highs and Lows of the Day 01/08: (PERI) (NCT) (CELG) High; (ALLT) (AU) Low
Jan 8, 2013 10:31AM Notable Analyst Rating Changes 01/08: (CELG) (MGM) (LUV) Upgraded; (FIO) (DECK) (MYL) Downgraded
Jan 8, 2013 06:53AM RBC Capital Upgrades Celgene (CELG) to Outperform
Jun 18, 2012 09:06AM RBC Capital Downgrades Celgene (CELG) to Sector Perform
Nov 30, 2011 11:05AM Notable Analyst Rating Changes 11/30: (LEAP) (AGU) (NAV) Upgraded; (NFLX) (SWN) (GLW) Downgraded
Oct 10, 2011 02:41PM Notable 52-Week Highs and Lows of the Day 10/10: (ATVI) (CELG) (VRUS) High; (S) (ALTH) (BABY) Low
Oct 10, 2011 07:31AM RBC Capital Upgrades Celgene (CELG) to Outperform
Feb 24, 2011 10:43AM Notable Analyst Rating Changes 02/24: (CLS) (CHK) (HOS) (HRB) Upgraded; (LULU) (CELG) (FLR) (RHT) Downgraded
Feb 24, 2011 08:07AM RBC Capital Upgrades Biogen (BIIB), Regeneron (REGN) to Outperform, Downgrades Celgene (CELG) to Sector Perform
Sep 2, 2009 10:14AM Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
Aug 6, 2009 10:18AM Notable Analyst Rating Changes 8/6: AXP, MGM, OWW, FCX, SPLS, DD Upgraded; CELG, FITB, OCNF, MELI, SHO Downgraded
Feb 4, 2009 09:41AM Notable Analyst Rating Changes 2/4: RVBD, UPS, RSYS Upgraded; ADM, DIS, STI, WYNN Downgraded
View Older Stories